Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/30/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Edward A. Berger

Wrong Dr. Edward A. Berger?


National Institute of Allergy and Infectious Diseases
6610 Rockledge Dr. Room 4800
Bethesda , Maryland 20892
United States

Company Description: NIAID conducts and supports research-at NIH, throughout the United States, and worldwide-to study the causes of infectious and immune-mediated diseases, and to...   more

Employment History

Board Memberships and Affiliations


  • Ph.D.
  • PhD
49 Total References
Web References
Advisory Boards: Institute of Human Virology, 30 Dec 2014 [cached]
Edward Berger, Ph.D., NIAID/NIH
The immunotoxin, known as 3B3-PE38, was ..., 9 Jan 2014 [cached]
The immunotoxin, known as 3B3-PE38, was created in 1998 in the laboratories of Edward A. Berger, Ph.D., of the National Institute of Allergy and Infectious Diseases, and Ira Pastan, Ph.D., of the National Cancer Institute, both part of NIH.
NIAID Director Anthony S. Fauci, M.D., and Edward A. Berger, Ph.D., senior investigator in the NIAID Laboratory of Viral Diseases, are available for comment.
14th CROI Video Library Page, 17 Sept 2011 [cached]
Edward Berger, PhD, Chief, Molecular Structure Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Disease, NIH, Bethesda, Maryland, USA His laboratory has had a long-standing interest in how enveloped viruses enter target cells. His group seeks to unravel the basic mechanisms of membrane fusion mediated by the interactions of viral envelope glycoprotein's with their target cell receptors, and to apply that knowledge to the development of novel strategies to treat and prevent virus infection. This work has expanded their studies to diverse enveloped viruses of significance into human health, including herpes viruses and flaviviruses.
Rediscovering Biology - Expert Interview Transcripts, 12 July 2006 [cached]
Edward A. Berger, PhD
Berger is chief of the Molecular Structure Section in the laboratory of viral diseases in NIAID and NIH.Berger's lab identified the first HIV co-receptor, a molecule that Dr. Berger and his colleagues dubbed "fusin."They showed that fusin must be present on the surface of CD4+ T cells in order for HIV to enter and infect these cells.Soon thereafter, Berger's group and others showed that other HIV strains use different co-receptors to gain entry into target cells.
But that has not proven so ..., 6 Mar 2007 [cached]
But that has not proven so far to be a big problem, according to Edward A. Berger of the National Institute of Allergy and Infectious Diseases, who played a key role in the discovery of the two portals.
Other People with the name "Berger":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.